Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 428, Issue 1-2, 1999, Pages 305-327

  Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Capsaicin; Chemoprevention; Curcumin; Diarylheptanoid; Epigallocatechin gallate; Gingerol; Paradol; Phytochemical; Resveratrol; Vanilloid; Yakuchinone

Indexed keywords

ANTIOXIDANT; ASBESTOS; BENZO[A]PYRENE; BETA CAROTENE; CAPSAICIN; CARCINOGEN; CURCUMIN; CYTOCHROME P450; DIHYDROCAPSAICIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; ETHYLMORPHINE N DEMETHYLASE; FLAVONOID; GINGEROL; GROWTH FACTOR; INTERLEUKIN 1ALPHA; LEUKOTRIENE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RESVERATROL; RETINOIC ACID; RETINOID; SHOGAOL; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; YAKUCHINONE A; YAKUCHINONE B;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; DIET; DRUG MECHANISM; HUMAN; INFLAMMATION; MEDICINAL PLANT; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CAPSAICIN; CATECHIN; CURCUMIN; DIET; FATTY ALCOHOLS; HUMANS; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHENOLS; PLANTS, EDIBLE; PLANTS, MEDICINAL; STILBENES;

ALPINIA OXYPHYLLA; CAPSICUM FRUTESCENS; CURCUMA LONGA; VITACEAE; ZINGIBER OFFICINALE; ZINGIBERACEAE;

EID: 0032813348     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00057-5     Document Type: Conference Paper

References (239)

1. Morse M.A., Stoner G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis. 14:1993;1737-1746.
2. Kelloff G.J., Hawk E.T., Crowell J.A., Boone C.W., Nayfield S.G., Perloff M., Steele V.E., Lubet R.A., Sigman C.C. Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology. 10:1996;1471-1480.
3. Mettlin C. Chemoprevention: will it work? Int. J. Cancer, Suppl. 10:1997;18-21.
4. Sporn M.B., Roberts A.B. Role of retinoids in differentiation and carcinogenesis. J. Natl. Cancer Inst. 73:1984;1381-1387.
5. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
6. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402:1998;151-158.
7. Ferguson L.R. Antimutagens as cancer chemopreventive agents in the diet. Mutat. Res. 307:1994;395-410.
8. Johnson I.T., Williamson G., Musk S.R.R. Anticarcinogenic factors in plant foods: a new class of nutrients? Nutr. Res. 7:1994;175-204.
9. Muto Y., Ninomiya M., Fujiki H. Present status of research on cancer chemoprevention in Japan. Jpn. J. Oncol. 20:1990;219-224.
10. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1994;1029-1035.
11. Edes T.E., Thomson W.H. Jr., Shah J.H. Beta-carotene and mammary carcinogenesis. J. Am. Coll. Nutr. 8:1993;426.
12. Chen L.-C., Sly L., Jones C.S., Tarone R., De Luca L.M. Differential effects of dietary β-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin. Carcinogenesis. 14:1993;713-717.
13. Yang C.S., Smith T.J., Hong J.-Y. Cytochrome P450 enzymes as targets for chemoprevention against chemical carcinogenesis: opportunities and limitations. Cancer Res. 54:1994;1982s-1986s. Suppl.
14. Paolini M., Mesirca R., Gialluca N., Bauer C., Biagi G.L., Cantelli-Forti G. On cancer chemoprevention: complications and limitations of some proposed strategies. Carcinogenesis. 16:1995;971-973.
15. Paolini M., Legator M.S. Healthy broccoli? Nature. 357:1992;448.
16. G.J. Kelloff, C.W. Boone, V.E. Steele, J.R. Fay, C.C. Sigman, Inhibition of chemical carcinogenesis, in: J.C. Arcos (Ed.), Chemical Induction of Cancer, Birkäuser, Basel, 1995, pp. 401-410.
17. Lotan R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87:1995;1655-1657.
18. Holzman D. Apoptosis provides new targets for chemotherapy. J. Natl. Cancer Inst. 88:1996;1098-1100.
19. Fesüs L., Szondy Z., Uray I. Probing the molecular program of apoptosis by cancer chemopreventive agents. J. Cell. Biochem., Suppl. 22:1995;151-161.
20. Müller I., Jenner A., Bruchelt G., Niethammer D., Halliwell B. Effect of concentration on the cytotoxic mechanism of doxorubicin - apoptosis and oxidative DNA damage. Biochem. Biophys. Res. Commun. 230:1997;254-257.
21. Yu W., Sanders B.G., Kline K. RRR-α-Tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr. Cancer. 27:1997;92-101.
22. Delia D., Aiello A., Fontanella F., Costa A., Miyashita T., Reed J.C., Pierotti M.A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)retinamide and effect of deregulated bcl-2. Blood. 85:1995;359-367.
23. 2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res. 58:1998;241-247.
24. Yu R., Mandlekar S., Harvey K.J., Ucker D.S., Kong A.-N. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 58:1998;402-408.
25. Sundaram S.G., Miller J. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis. 17:1996;669-673.
26. Rigas B., Goldman I.S., Levin L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
27. Levy G.N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
28. Dubois R.N. Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas. Gastroenterology. 108:1995;1310-1314.
29. Giardiello F.M., Hamilton S.R., Krush A.J., Piantodosi S., Hylind L.M., Celano P., Booker S.V., Robinson R.C., Offerhaus G.J.A. Treatment of colorectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328:1993;1313-1316.
30. Bellosillo B., Pique M., Barragan M., Castano E., Villamor N., Colomer D., Montserrat E., Pons G., Gil J. Aspirin and salicylate induce apoptosis and activation of caspases in B cell chronic lymphotropic leukemia cells. Blood. 92:1998;1406-1414.
31. Piazza G.A., Rahm A.L.K., Krutzsch M., Sperl G., Paranka N.S., Gross P.H., Brendel K., Burt R.W., Alberts D.S., Pamukcu R., Ahnen D.J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55:1995;3110-3116.
32. Samaha H.S., Kelloff G.J., Steele V., Rao C.V., Reddy B.S. Modulation of apoptosis by sulindac, curcumin, phenethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptosis index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res. 57:1997;1301-1305.
33. Lee E., Park K.-K., Lee J.-M., Chun K.-S., Kang J.-Y., Lee S.S., Surh Y.-J. Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae). Carcinogenesis. 19:1998;1377-1381.
34. Kuo M.-L., Huang T.-S., Lin J.-K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta. 1317:1996;95-100.
35. Jiang M.-C., Yang-Yen H.-F., Yen J.J.-Y., Lin J.-K. Curcumin induces apoptosis in immortalized NIH3T3 and malignant cancer cell lines. Nutr. Cancer. 26:1996;111-120.
36. Lee E., Surh Y.-J. Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett. 134:1998;163-168.
37. Surh Y.-J., Lee S.S. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci. 56:1995;1845-1855.
38. Surh Y.-J., Lee S.S. Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? Food Chem. Toxicol. 34:1996;313-316.
39. Miller M.S., Brendel K., Burks T.F., Sipes I.G. Interactions of capsaicinoids with drug-metabolizing systems. Biochem. Pharmacol. 32:1983;547-551.
40. Surh Y.-J., Ahn S.H., Kim K.-C., Park J.-B., Sohn Y.W., Lee S.S. Metabolism of capsaicinoids: evidence for aliphatic hydroxylation and its pharmacological implications. Life Sci. 56:1995;PL305-PL311.
41. Hamid M.R., Bachmann E., Metwally S.A. Interaction of capsaicin with mixed function oxidases: ex vivo and in vivo studies. J. Drug Res. Egypt. 16:1995;29-36.
42. Modly C.E., Das M., Don P.S.C., Marcelo C.L., Mukhtar H., Bickers D.R. Capsaicin as an in vitro inhibitor of benzo[a]pyrene metabolism and its DNA binding in human and murine keratinocytes. Drug Metab. Dispos. 14:1986;413-417.
43. Jang J.J., Kim S.H., Yun T.K. Inhibitory effect of capsaicin on mouse lung tumor development. In Vivo. 33:1989;49-54.
44. 1. Nutr. Cancer. 15:1991;27-32.
45. Miller C.H., Zhang Z., Hamilton S.M., Teel R.W. Effects of capsaicin on liver microsomal metabolism of the tobacco-specific nitrosamine NNK. Cancer Lett. 75:1993;45-52.
46. Teel R.W. Effect of phytochemicals on the mutagenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium strain TA1535. Phytother. Res. 7:1993;248-251.
47. Zhang Z., Hamilton S.M., Stewart C., Strother A., Teel R.W. Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 13:1993;2341-2346.
48. Gannett P.M., Iversen P., Lawson T. The mechanism of inhibition of cytochrome P450 IIE1 by dihydrocapsaicin. Bioorg. Chem. 18:1990;185-198.
49. Surh Y.-J., Lee R.C.-J., Park K.K., Mayne S.T., Liem A., Miller J.A. Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis. 16:1995;2467-2471.
50. De A.K., Ghosh J.J. Studies on capsaicin inhibition of chemically-induced lipid peroxidation in the lung and liver tissues of rat. Phytother. Res. 6:1992;34-37.
51. De A.K., Ghosh J.J. Capsaicin pretreatment protects free radical induced rat lung damage on exposure to gaseous chemical lung irritants. Phytother. Res. 3:1989;159-161.
52. De A.K., Agarwal K., Mukherjee A., Sengupta D. Inhibition by capsaicin against cyclophosphamide-induced clastogenicity and DNA damage in mice. Mutat. Res. 335:1995;253-258.
53. Gabor M., Razga Z. Development and inhibition of mouse ear edema induced with capsaicin. Agents and Actions. 36:1992;83-86.
54. Inoue H., Nagata N., Koshihara Y. Involvement of substance P as a mediator in capsaicin-induced mouse ear edema. Inflammation Res. 44:1995;470-474.
55. Pulla Reddy A.Ch., Lokesh B.R. Studies on anti-inflammatory activity of spice principles and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in rats. Ann. Nutr. Metab. 38:1994;349-358.
56. Wang J.-P., Hsu M.-F., Teng C.-M. Antiplatelet effect of capsaicin. Thromb. Res. 36:1984;497-507.
57. Wang J.-P., Hsu M.-F., Hsu T.-P., Teng C.-M. Antihemostatic and antithrombotic effects of capsaicin in comparison with aspirin and indomethacin. Thromb. Res. 37:1985;669-679.
58. Sylvester D.M., LaHann T.R. Effects of capsaicinoids on platelet aggregations. Proc. West. Pharmacol. Soc. 32:1989;95-100.
59. H.O.J. Collier, W.J. McDonald-Gibson, S.A. Saeed, Stimulation of prostaglandin biosynthesis by capsaicin, ethanol, and tyramine, Lancet (1975) 702.
60. Wang J.-P., Hsu M.-F., Teng C.-M. Antiplatelet effect of capsaicin. Thromb. Res. 36:1984;497-507.
61. Clementi G., Amico-Rexas M., Caruso A., Cutuli V.M.C., Prato A., Maugeri S., de Bernardis E., Scapagnini U. Effects of CGRP in different models of mouse ear inflammation. Life Sci. 54:1994;PL119-PL124.
62. Park K.-K., Chun K.-S., Yook J.-I., Surh Y.-J. Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis. Anticancer Res. 18:1998;4201-4206.
63. Morre D.J., Chueh P.J., Morre D.M. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1831-1835.
64. Morre D.J., Sun E., Geilen C., Wu L.Y., de Cabo R., Krasagakis K., Orfanos C.E., Morre D.M. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur. J. Cancer. 32A:1996;1995-2003.
65. Wolvetang E.J., Larm J.A., Moutsoulas P., Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ. 7:1996;1315-1325.
66. Kim J.-D., Kim J.-M., Pyo J.-O., Kim S.-Y., Kim B.-S., Yu R., Han I.-S. Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett. 120:1997;235-241.
67. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
68. Leonardo M.J. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
69. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radical Res. Commun. 17:1992;221-237.
70. Handel M.L. Transcription factors AP-1 and NF-κB: where steroids meet the gold standard of anti-rheumatic drugs. Inflammation Res. 46:1997;282-286.
71. Chabot-Fletcher M. A role for transcription factor NF-κB in inflammation. Inflammation Res. 46:1997;1-2.
72. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
73. Kaul N., Choi J., Forman H.J. Transmembrane redox signaling activates NF-κB in macrophages. Free Radical Biol. Med. 24:1998;202-207.
74. Singh S., Natarajan N., Aggarwal B.B. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-κB activation by diverse agents. J. Immunol. 157:1996;4412-4420.
75. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
76. Macho A., Blazquez M.-V., Navas P., Munoz E. Induction of apoptosis by vanilloid compounds does not require de novo gene transcription and activator protein 1 activity. Cell Growth Differ. 9:1998;277-286.
77. Mustafa T., Srivastava K.C., Jensen K.B. Drug development report (9): pharmacology of ginger, Zingiber officinale. J. Drug Dev. 6:1993;25-39.
78. Mascolo N., Jain R., Jain S.C., Capasso F. Ethnopharmacologic investigation of ginger (Zingiber officinale). J. Ethnopharmacol. 27:1989;129-140.
79. Aeschbach R., Loliger J., Scott B.C., Murcia A., Butler J., Halliwell B., Aruoma O.I. Antioxidant actions of thymol, carbacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem. Toxicol. 32:1994;31-36.
80. Kikuzaki H., Nakatani N. Antioxidant effects of some ginger constituents. J. Food Sci. 58:1993;1407-1410.
81. H. Kikuzaki, Y. Kawasaki, N. Nakatani, Structure of antioxidative compounds in ginger, in: C.-T. Ho, T. Osawa, M.-T. Huang, R.T. Rosen (Eds.), Food Phytochemicals for Cancer Prevention II, American Chemical Society, Washington, DC, 1994, pp. 237-243.
82. Chang W.-S., Chang Y.-H., Lu F.-J., Chiang H.-C. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res. 14:1994;501-506.
83. Guh J.-H., Ko F.-N., Jong T.-T., Teng C.-M. Antiplatelet effect of gingerol isolated from Zingiber officinale. J. Pharm. Pharmacol. 47:1995;329-332.
84. S. Kawakishi, Y. Morimitsu, T. Osawa, Chemistry of ginger components and inhibitory factors of the arachidonic acid cascade, in: C.-T. Ho, T. Osawa, M.-T. Huang, R. Rosen (Eds.), Food Phytochemicals for Cancer Prevention II, American Chemical Society, Washington, DC, 1994, pp. 244-250.
85. Flynn D.L., Rafferty M.F. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins, Leukotrienes and Medicine. 22:1986;357-360.
86. Kiuchi F., Shibuya M., Sankawa U. Inhibitors of prostaglandin biosynthesis from Alpinia officinarum. Chem. Pharm. Bull. 30:1982;2279-2282.
87. Kiuchi F., Iwakami S., Shibuya M., Hanaoka F., Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem. Pharm. Bull. 40:1992;387-391.
88. Park K.-K., Chun K.-S., Lee J.-M., Lee S.S., Surh Y.-J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 129:1998;139-144.
89. Katiyar S.K., Agarwal R., Mukhtar H. Inhibition of tumor promotion in SENKAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res. 56:1996;1023-1030.
90. Yoshimi N., Wang A., Morishita Y., Tanaka T., Sugie S., Kawai K., Yamahara J., Mori H. Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn. J. Cancer Res. 83:1992;1273-1278.
91. Suzuki F., Kobayashi M., Komatsu Y., Kato A., Pollard R.B. Keishi-ka-kai-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 17(2A):1997;873-878.
92. Surh Y.-J., Park K.-K., Chun K.-S., Lee J.-M., Lee E., Lee S.S. Anti-tumor promoting activities of selected pungent phenolic substances present in ginger. J. Environ. Toxicol. Pathol. Oncol. 18:1999;131-139.
93. Ammon H.P.T., Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 57:1991;1-7.
94. Srimal R.C., Dhawan B.N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25:1973;447-452.
95. Sharma O.P. Antioxidative activity of curcumin and related compounds. Biochem. Pharmacol. 25:1976;1811-1812.
96. Rao T.S., Basu N., Siddiqui H.H. Anti-inflammatory activity of curcumin analogs. Indian J. Med. Sci. 75:1982;574-578.
97. Mukhopadhyay A., Basu N., Ghatak N., Gujral P.K. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents and Actions. 12:1982;508-515.
98. Toda S., Miyase T., Arichi H., Tanizawa H., Takino Y. Natural antioxidants: III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm. Bull. 33:1985;1725-1728.
99. Srivastava R., Srimal R.C. Modification of certain inflammation-induced biochemical changes by curcumin. Indian J. Med. Res. 81:1985;215-223.
100. Subramanian M., Sreejayan, Rao M.N.A., Devasagayam T.P.A., Singh B.B. Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat. Res. 311:1994;249-255.
101. Lin J.K., Shih C.-A. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis. 15:1994;1717-1721.
102. Sugiyama Y., Kawakishi S., Osawa T. Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol. 52:1996;519-525.
103. Nagabhusan M., Amonkar A.J., Bhide S.V. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem. Toxicol. 25:1987;545-547.
104. Abraham S.K., Sarma L., Kesavan P.C. Protective effects of chlorogenic acid, curcumin and β-carotene against γ-radiation-induced in vivo chromosome damage. Mutat. Res. 303:1993;109-112.
105. Lahiri M., Maru G.B., Bhide S.V. Effect of four plant phenols, β-carotene and α-tocopherol on benzo[a]pyrene-induced DNA damage in the mouse forestomach mucosa (target organ) and bone marrow polychromatic erythrocytes (non-target organ). Mutat. Res. 303:1993;97-100.
106. Mukundan M.A., Chacko M.C., Annapurna V.V., Krishnaswamy K. Effect of turmeric and curcumin on BP-DNA adducts. Carcinogenesis. 14:1993;493-496.
107. 3H )benzopyrene-DNA interaction in vitro in the presence of rat and mouse liver postmitochondrial fraction Cancer Lett. 73:1993;35-39.
108. Deshpande S.S., Maru G.B. Effects of curcumin on the formation of benzo[a]pyrene derived DNA adducts in vitro. Cancer Lett. 96:1995;71-80.
109. Kiso Y., Suzuki Y., Watanabe N., Oshima Y., Hikino H. Antihepatotoxic principles of curcumin longa rhizomes. Planta Med. 49:1983;185-187.
110. Soni K.B., Rajan A., Kuttan R. Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett. 66:1992;115-121.
111. Soudamini K.K., Kuttan R. Inhibition of chemical carcinogenesis by curcumin. J. Ethnopharmacol. 27:1989;227-233.
112. Nagabhushan M., Bhide S.V. Curcumin as an inhibitor of cancer. J. Am. Coll. Nutr. 11:1992;192-198.
113. Conney A.H., Lou Y.-R., Xie J.-G., Osawa T., Newmark H.L., Liu Y., Chang R.L., Huang M.-T. Some perspectives on dietary inhibition of carcinogenesis; studies with curcumin and tea. Proc. Soc. Exp. Biol. Med. 216:1997;234-245.
114. Huang M.-T., Smart R.C., Wong C.-Q., Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48:1988;5941-5946.
115. Lu Y.P., Chang R.L., Huang M.-T., Conney A.H. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis. 14:1993;293-297.
116. Huang M.-T., Ma W., Yen P., Xie J.-G., Han J., Frenkel K., Grunberger D., Conney A.H. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis. 18:1997;83-88.
117. Huang M.-T., Lusz T., Ferraro T., Abidi T.F., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:1991;813-819.
118. Rao C.V., Rivenson A., Simi B., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:1995;259-266.
119. Shih C.-A., Lin J.-K. Inhibition of 8-hydroxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis. 14:1993;709-712.
120. Joe B., Lokesh B.R. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta. 1224:1994;255-263.
121. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., Kuttan R. Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett. 94:1995;79-83.
122. Brouet I., Ohshima H. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 206:1995;533-540.
123. Chan M.-Y., Ho C.-T., Huang H.-I. Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett. 96:1995;23-29.
124. Chan M.M., Huang H.I., Fenton M.R., Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol. 55:1998;1955-1962.
125. Liu J.-Y., Lin S.-J., Lin J.-K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoylphorbol-13-acetate in NIH3T3 cells. Carcinogenesis. 14:1993;857-861.
126. Kakar S.S., Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 87:1994;85-89.
127. Korutla L., Kumar R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta. 1224:1994;597-600.
128. Korutla L., Cheung J.Y., Mendelsohn J., Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis. 16:1995;1741-1745.
129. Reddy S., Aggarwal B.B. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 341:1994;19-22.
130. Bierhaus A., Zhang Y., Quehenberger P., Luther T., Haase M., Müller M., Mackman N., Ziegler R., Nawroth P.P. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB. Thrombosis and Haemostasis. 77:1997;772-782.
131. Huang T.-S., Lee S.-C., Lin J.-K. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 88:1991;5292-5296.
132. Chan M.M.-Y. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49:1995;1551-1556.
133. Singh S., Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin. J. Biol. Chem. 270:1995;24995-25000.
134. Hanif R., Qiao L., Shiff S.J., Rigas B. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J. Lab. Clin. Med. 130:1997;576-584.
135. Mehta K., Pantazis P., McQueen T., Aggrawal B.B. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anti-Cancer Drugs. 8:1997;470-481.
136. Chen X., Hasuma T., Yano Y., Yoshimata T., Morishima Y., Wang Y., Otani S. Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res. 17:1997;2555-2564.
137. Ciolino H.P., Daschner P.J., Wang T.T.Y., Yeh G.C. Effects of curcumin on the arylhydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 56:1998;197-206.
138. Lin L.-I., Ke Y.-F., Ko Y.-C., Lin J.-K. Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell division in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology. 55:1998;349-353.
139. Kang J.-Y., Lee E., Lee J.-M., Chun K.-S., Park K.-K., Sohn Y., Kim O.H., Surh Y.-J. Induction of apoptosis in HL-60 cells and inhibition of mouse skin tumor promotion by diarylheptanoids from Alpinia oxyphylla Miquel (Zingiberaceae). Proc. Am. Assoc. Cancer Res. 39:1998;641.
140. Chun K.-S., Park K.-K., Kim J.-H., Kim H.-S., Sohn Y., Surh Y.-J. Inhibition of mouse skin tumor promotion and suppression of phorbol ester-induced NF-κB and AP-1 activation by diarylheptanoids derived from Alpinia oxyphylla Miquel. Proc. Am. Assoc. Cancer Res. 40:1999;363.
141. Claeson P., Pongprayoon U., Sematong T., Tuchinada P., Reutrakul V., Soontornsaratune P., Taylor W.C. Non-phenolic linear diarylheptanoids from Curcuma xanthorrhiza: a novel type of topical anti-inflammatory agents: structure-activity relationship. Planta Med. 62:1996;236-240.
142. Doug H., Chen S.X., Xu H.X., Kadota S., Namba T. A new antiplatelet diarylheptanoid from Alpinia blepharocalyx. J. Nat. Prod. 61:1998;142-144.
143. Prasain J.K., Tezuka Y., Hase K., Basnet P., Dong H., Namba T., Kadota S. Inhibitory effect of diarylheptanoids on nitric oxide production in activated murine macrophages. Biol. Pharm. Bull. 21:1998;371-374.
144. Syu W.-J., Shen C.-C., Don M.-J., Ou J.-C., Lee G.-H., Sun C.-M. Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. J. Nat. Prod. 61:1998;1531-1534.
145. Roth G.N., Chandra A., Nair M.G. Novel bioactivities of Curcuma longa constituents. J. Nat. Prod. 61:1998;542-545.
146. Pace-Asciak C.R., Hahn S., Diamndis E.P., Soleas G., Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta. 235:1995;207-219.
147. Fauconneau B., Wafo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61:1997;2103-2110.
148. Kimura Y., Okuda H., Kubo M. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. J. Ethnopharmacol. 45:1995;131-139.
149. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.S.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
150. Teel R.W., Huynh H. Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett. 133:1998;135-141.
151. Uenobe F., Nakamura S.-i., Miyazawa M. Antimutagenic effect of resveratrol against Trp-P-1. Mutat. Res. 373:1997;197-200.
152. Chanvitayapongs S., Draczynska-Lusiak B., Sun A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. NeuroReport. 8:1997;1499-1502.
153. Sun A.Y., Chen Y.M., James-Kracke M., Wixom P., Cheng Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem. Res. 22:1997;1187-1192.
154. Draczynska-Lusiak B., Doung A., Sun A.Y. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer's disease. Mol. Chem. Neuropathol. 33:1998;139-148.
155. Draczynska-Lusiak B., Chen Y.M., Sun A.Y. Oxidized lipoproteins activate NF-κB binding activity and apoptosis in PC12 cells. NeuroReport. 9:1998;527-532.
156. Mgbonyebi O.P., Russo J., Russo I.H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 12:1998;865-869.
157. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421:1998;277-279.
158. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273:1998;21875-21882.
159. Jang M., Pezzuto J.M. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett. 134:1998;81-89.
160. Surh Y.-J., Hurh Y.-J., Kang J.-Y., Lee E., Kong G., Lee S.J. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 136:1999;1-10.
161. 2 phase transition. Biochem. Biophys. Res. Commun. 250:1998;53-58.
162. Clement M.-V., Hirpara J.L., Chawdhury S.-H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:1998;996-1002.
163. Gehm B.D., McAndrews J.M., Chien P.-Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14138-14143.
164. Stahl S., Chun T.Y., Gray W.G. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol. Appl. Pharmacol. 152:1998;41-48.
165. Fujiki H., Suganuma M., Okabe S., Komori A., Sueoka E., Sueoka N., Kozu T., Sakai Y. Japanese green tea as a cancer preventive in humans. Nutr. Rev. 54:1996;S67-S70.
166. Fujiki H., Suganuma M., Okabe S., Sueoka N., Komori A., Sueoka E., Kozu T., Tada Y., Suga K., Imai K., Nakachi K. Cancer inhibition by green tea. Mutat. Res. 402:1998;307-310.
167. Jankun J., Selman S.H., Swiercz R., Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature. 387:1997;561.
168. Yang C.S. Inhibition of carcinogenesis by tea. Nature. 389:1997;134-135.
169. Nakachi K., Suemasu K., Suga K., Takeo T., Imai K., Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89:1998;254-261.
170. Fujiki H., Yoshizawa S., Horiuchi T., Suganuma M., Yatsunami J., Nishiwaki S., Okabe S., Nishiwaki-Matsushima R., Okuda T., Sugimura T. Anticarcinogenic effects of (-)-epigallocatechin gallate. Prev. Med. 21:1992;503-509.
171. Komori A., Yatsunami J., Okabe S., Abe S., Hara K., Suganuma M., Kim S.J., Fujiki H. Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 23:1993;186-190.
172. Fujiki H., Suganuma M., Komori A., Yatsunami J., Okabe S., Ohta T., Sueoka E. A new tumor promotion pathway and its inhibitors. Cancer Detect. Prev. 18:1994;1-7.
173. Ho C.T., Chen Q., Shi H., Zhang K.Q., Rosen R.T. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev. Med. 21:1992;520-525.
174. Wei H., Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis. 14:1993;1195-1201.
175. Bhimani R.S., Troll W., Grunberger D., Frenkel K. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res. 53:1993;4528-4533.
176. Yoshino K., Hara Y., Sano M., Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol. Pharm. Bull. 17:1994;146-149.
177. 2+-mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull. 18:1995;1-4.
178. Sano M., Takahashi Y., Yoshino K., Shimoi K., Nakamura Y., Tomita I., Oguni I., Konomoto H. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol. Pharm. Bull. 18:1995;1006-1008.
179. Hasegawa R., Chujo T., Sai-Kato K., Umemura T., Tanimura A., Kurokawa Y. Preventive effects of green tea against liver oxidative DNA damage and hepatotoxicity in rats treated with 2-nitropropane. Food Chem. Toxicol. 33:1995;961-970.
180. Sai-Kato K., Umemura T., Takagi A., Hasegawa R., Tanimura A., Kurokawa Y. Pentachlorophenol-induced oxidative DNA damage in mouse liver and protective effect of antioxidants. Food Chem. Toxicol. 33:1995;877-882.
181. Fiala E.S., Sodum R.S., Bhattacharya M., Li H. (-)-Epigallocatechin gallate, a polyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine. Experientia. 52:1996;922-926.
182. Yoshioka H., Akai G., Yoshinaga K., Hasegawa K., Yoshioka H. Protecting effect of a green tea percolate and its main constituents against gamma ray-induced scission of DNA. Biosci. Biotechnol. Biochem. 60:1996;117-119.
183. Yoshioka H., Kurosaki H., Yoshinaga K., Saito K., Yoshioka H. Beta-ray-induced scission of DNA in tritiated water and protection by a green tea percolate and (-)-epigallocatechin gallate. Biosci. Biotechnol. Biochem. 61:1997;1560-1563.
184. Ishikawa T., Suzukawa M., Ito T., Yoshida H., Ayaori M., Nishiwaki M., Yonemura A., Hara Y., Nakamura H. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 66:1997;261-266.
185. Hasaniya N., Youn K., Xu M., Hernaez J., Dashwood R. Inhibitory activity of green and black tea in a free radical-generating system using 2-amino-3-methylimidazo[4,5-f]-quinoline as substrate. Jpn. J. Cancer Res. 88:1997;553-558.
186. Aucamp J., Gaspar A., Hara Y., Apostolides Z. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res. 17:1997;4381-4385.
187. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 52:1997;465-472.
188. Soliman K.F., Mazzio E.A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc. Soc. Exp. Biol. Med. 218:1998;390-397.
189. Chan M.M., Fong D., Ho C.T., Huang H.I. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem. Pharmacol. 54:1997;1281-1286.
190. Chan M.M., Ho C.T., Huang H.I. Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett. 96:1995;23-29.
191. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 436:1999;69-97.
192. Fujita Y., Yamane T., Tanaka M., Kuwata K., Okuzumi J., Takahashi T., Fujiki H., Okuda T. Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine in mouse duodenum. Jpn. J. Cancer Res. 80:1989;503-505.
193. Yamane T., Nakatani H., Kikuoka N., Matsumoto H., Iwata Y., Kitao Y., Oya K., Takahashi T. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer. 77:1996;1662-1667. Suppl. 8.
194. Yamane T., Takahashi T., Kuwata K., Oya K., Inagake M., Kitao Y., Suganuma M., Fujiki H. Inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res. 55:1995;2081-2084.
195. Matsumoto N., Kohri T., Okushio K., Hara Y. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat. Jpn. J. Cancer Res. 87:1996;1034-1038.
196. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Finnegan-Olive T., Lou Y.R., Mitchell J.M., Laskin J.D., Newmark H., Yang C.S., Conney A.H. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis. 13:1992;947-954.
197. Katiyar S.K., Agarwal R., Wang Z.Y., Bhatia A.K., Mukhtar H. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in SENCAR mouse skin. Nutr. Cancer. 18:1992;73-83.
198. Wang Z.Y., Huang M.T., Ho C.T., Chang R., Ma W., Ferraro T., Reuhl K.R., Yang C.S., Conney A.H. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res. 52:1992;6657-6665.
199. Katiyar S.K., Mohan R.R., Agarwal R., Mukhtar H. Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols. Carcinogenesis. 18:1997;497-502.
200. Gensler H.L., Timmermann B.N., Valcic S., Wachter G.A., Dorr R., Dvorakova K., Alberts D.S. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr. Cancer. 26:1996;325-335.
201. Xu Y., Ho C.T., Amin S.G., Han C., Chung F.L. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52:1992;3875-3879.
202. Chung F.L., Morse M.A., Eklind K.I., Xu Y. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea. Ann. N. Y. Acad. Sci. 686:1993;186-201.
203. Horikawa K., Mohri T., Tanaka Y., Tokiwa H. Moderate inhibition of mutagenicity and carcinogenicity of benzo[a]pyrene, 1,6-dinitropyrene and 3,9-dinitrofluoranthene by Chinese medicinal herbs. Mutagenesis. 9:1994;523-526.
204. Nishida H., Omori M., Fukutomi Y., Ninomiya M., Nishiwaki S., Sugnuma M., Moriwaki H., Muto Y. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn. J. Cancer Res. 85:1994;221-225.
205. Komatsu K., Tauchi H., Yano N., Endo S., Matsuura S., Shoji S. Inhibitory action of (-)-epigallocatechin gallate on radiation-induced mouse oncogenic transformation. Cancer Lett. 112:1997;135-139.
206. Kitano K., Nam K.Y., Kimura S., Fujiki H., Imanishi Y. Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys. Chem. 65:1997;157-164.
207. Suganuma M., Okabe S., Sueoka E., Iida N., Komori A., Kim S.J., Fujiki H. A new process of cancer prevention mediated through inhibition of tumor necrosis factor-α expression. Cancer Res. 56:1996;3711-3715.
208. Sigler K., Ruch R.J. Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea. Cancer Lett. 69:1993;15-19.
209. Hu G., Han C., Chen J. Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice. Nutr. Cancer. 24:1995;203-209.
210. Katiyar S.K., Rupp C.O., Korman N.J., Agarwal R., Mukhtar H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin-tumor promoter-caused induction of epidermal interleukin-1α mRNA and protein expression in SENCAR mice by green tea polyphenols. J. Invest. Dermatol. 105:1995;394-398.
211. Sakagami H., Takeda M., Sugaya K., Omata T., Takahashi H., Yamamura M., Hara Y., Shimamura T. Stimulation by epigallocatechin gallate of interleukin-1 production by human peripheral blood mononuclear cells. Anticancer Res. 15:1995;971-974.
212. Lee S.F., Lin J.K. Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr. Cancer. 28:1997;177-183.
213. Dong Z., Ma W., Huang C., Yang C.S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 57:1997;414-419.
214. Weisburger J.H., Rivenson A., Aliaga C., Reinhardt J., Kelloff G.J., Boone C.W., Steele V.E., Balentine D.A., Pittman B., Zang E. Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer. Proc. Soc. Exp. Biol. Med. 217:1998;104-108.
215. Liao S., Umekita Y., Guo J., Kokontis J.M., Hiipakka R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96:1995;239-243.
216. Araki R., Inoue S., Osborne M.P., Telang N.T. Chemoprevention of mammary preneoplasia, in vitro effects of a green tea polyphenol. Ann. N. Y. Acad. Sci. 768:1995;215-222.
217. Katdare M., Singhal H., Newmark H., Osborne M.P., Telang N.T. Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors. Cancer Lett. 111:1997;141-147.
218. Hirose M., Mizoguchi Y., Yaono M., Tanaka H., Yamaguchi T., Shirai T. Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene. Cancer Lett. 112:1997;141-147.
219. Lea M.A., Xiao Q., Sadhukhan A.K., Cottle S., Wang Z.Y., Yang C.S. Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett. 68:1993;231-236.
220. Valcic S., Timmermann B.N., Alberts D.S., Wachter G.A., Krutzsch M., Wymer J., Guillen J.M. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anti-Cancer Drugs. 7:1996;461-468.
221. Hibasami H., Achiwa Y., Fujikawa T., Komiya T. Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res. 16:1996;1943-1946.
222. Achiwa Y., Hibasami H., Katsuzaki H., Imai K., Komiya T. Inhibitory effects of persimmon (Diospyros kaki) extract and related polyphenol compounds on growth of human lymphoid leukemia cells. Biosci. Biotechnol. Biochem. 61:1997;1099-1101.
223. Okabe S., Suganuma M., Hayashi M., Sueoka E., Komori A., Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res. 88:1997;639-643.
224. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., Fujiki H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 59:1999;44-47.
225. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89:1997;1881-1886.
226. Liang Y.C., Lin-shiau S.Y., Chen C.F., Lin J.K. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell. Biochem. 67:1997;55-65.
227. Kennedy D.O., Nishimura S., Hasuma T., Yano Y., Otani S., Matsui-Yuasa I. Involvement of protein tyrosine phosphorylation in the effect of green tea polyphenols on Ehrlich ascites tumor cells in vitro. Chem.-Biol. Interact. 110:1998;159-172.
228. Khafif A., Schantz S.P., Chou T.C., Edelstein D., Sacks P.G. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 19:1998;419-424.
229. Khafif A., Schantz S.P., al-Rawi M., Edelstein D., Sacks P.G. Green tea regulates cell cycle progression in oral leukoplakia. Head and Neck. 20:1998;528-534.
230. Katdare M., Osborne M.P., Telang N.T. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals. Oncol. Rep. 5:1998;311-315.
231. Hibasami H., Komiya T., Achiwa Y., Ohnishi K., Kojima T., Nakanishi K., Akashi K., Hara Y. Induction of apoptosis in human stomach cancer cells by green tea catechins. Oncol. Rep. 5:1998;527-529.
232. Yang G.Y., Liao J., Kim K., Yurkow E.J., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:1998;611-616.
233. Paschka A.G., Butler R., Young C.Y. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 130:1998;1-7.
234. Liao S., Hiipakka R.A. Selective inhibition of steroid 5 α-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun. 214:1995;833-838.
235. Chen Z.P., Schell J.B., Ho C.T., Chen K.Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 129:1998;173-179.
236. Sazuka M., Imazawa H., Shoji Y., Mita T., Hara Y., Isemura M. Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins. Biosci. Biotechnol. Biochem. 61:1997;1504-1506.
237. Taniguchi S., Fujiki H., Kobayashi H., Go H., Miyado K., Sadano H., Shimokawa R. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett. 65:1992;51-54.
238. Isemura M., Suzuki Y., Satoh K., Narumi K., Motomiya M. Effects of catechins on the mouse lung carcinoma cell adhesion to the endothelial cells. Cell Biol. Int. 17:1993;559-564.
239. Naasani I., Seimiya H., Tsuruo T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem. Biophys. Res. Commun. 249:1998;391-396.